A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2004
11/03/2004	CN1543345A Methods for selective immunomodulation using pimecrolimus
11/03/2004	CN1542135A Preparation and use for phospholipase A2 congener from Agkistrodon blomhoffii Ussurensis of Changbai Mountains and genes encoding same
11/03/2004	CN1542017A An antibiotic peptide and its coded sequence and use
11/03/2004	CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004	CN1541714A Gene transfer-mediated angiogenesis therapy
11/03/2004	CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels
11/03/2004	CN1541708A Use of insulin promoting peptide and nutrient, parenteral nutrition composition and pharmaceuticals
11/03/2004	CN1541707A Medicinal composition for treating serious acute respiratory syndrome
11/03/2004	CN1541706A Inhibitor and stimulator of stem cell proliferation and uses thereof
11/03/2004	CN1541656A Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
11/03/2004	CN1174097C Macrophage activating factors derived from cloned vitamin D binding protein
11/03/2004	CN1174094C Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes
11/03/2004	CN1173992C Hybrid peptide with vascularization inhibiting activity
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173990C Depsipeptide compound
11/03/2004	CN1173745C Use of chemically modified methioninase in anti-methionine and anti-homocysteine chemotherapy
11/03/2004	CN1173739C Human growth hormone-containing aqueous pharmaceutical composition
11/03/2004	CN1173738C Utilization of interferon alpha 5 in the preparation of drugs for viral hepatopathies
11/03/2004	CN1173737C Application of Hepcidin in pharmacy
11/03/2004	CN1173736C Use of interleukin-18 inhibitors in inhibiting tumor metastasis
11/03/2004	CN1173735C Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease
11/03/2004	CN1173734C Health-care food for improving prostatoplasia
11/03/2004	CN1173733C Process for preparing dried soybean polypeptide powder with fat reducing action
11/03/2004	CN1173694C Pharmaceutical composition for treatment of acute disorders
11/02/2004	US6812376 Exclusively permeable to chloride ions; for diagnosis/therapy; drug screening; measures swimming of transgenic nematodes
11/02/2004	US6812340 Inhibition of bone tumor formation using antisense cDNA therapy
11/02/2004	US6812336 For selectively inhibiting signal transduction pathways to regulate gene expression
11/02/2004	US6812328 High cooperativity in oxygen binding; rhb (beta n108q) exhibits enhanced stability against autoxidation; wherein the asparagine residue at position 108 of the beta-chains is replaced by a glutamine residue; genetic engeineering;
11/02/2004	US6812327 Neutrokine-alpha polypeptides
11/02/2004	US6812326 Tumor necrosis factor receptor-associated factor (traf) protein-interacting hereditary multiple extoses (trex) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
11/02/2004	US6812258 Cancer treatment composition and method using natural plant essential oils
11/02/2004	US6812257 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
11/02/2004	US6812256 Reducing weight in mammals; anorectic action
11/02/2004	US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004	US6812221 Immobilization
11/02/2004	US6812210 Urocortin-III and uses thereof
11/02/2004	US6812209 Conjugate consisting of an active substance and a non-exogenous native protein
11/02/2004	US6812208 Methods to improve neural outcome
11/02/2004	US6812207 Hemoglobin mutants that reduce heme loss
11/02/2004	US6812206 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex
11/02/2004	US6812205 Atherosclerosis
11/02/2004	US6812203 Treatment of cd40 and/or nf-kb related diseases, antiinflammatory, antitumor
11/02/2004	US6812034 Diagnosing calcification of arteries; obtain blood sample, screen for the presence of fetuin-mineral complex in blood, amplified concentration of fetuin complex indicates calcification of arteries and other soft tissues
11/02/2004	US6812026 Antibodies directed against binding-associated epitopes
11/02/2004	US6812017 Phospholipase for use in the prevention and treatment of inflammatory, cancer, heart, brain, lung, ischemic and respiratory disorders
11/02/2004	US6812015 For drug screening; diagnosis/therapy of metabolic disorders/cancer/viral infections/immune disorders
11/02/2004	US6812003 Compounds and methods for modulating cell-adhesion mediated drug resistance
11/02/2004	US6812002 Stimulating and modulating bone cell differentiation and bone formation; bone disorders including osteopetrosis and osteoporosis; genetic engineeing; gene therapy;
11/02/2004	US6811989 Pancreatic islet cell antigens obtained by molecular cloning
11/02/2004	US6811987 For treating tumors, hemopathy, hiv infection, immunological disease, inflammation; drug screening; genetic engineering
11/02/2004	US6811972 For preparing a hybridoma cell line which specifically recognizes and binds tumor associated antigen; antibodies; prostate carcinoma tumor antigen gene-1
11/02/2004	US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
11/02/2004	US6811782 Peptide composition as immunogen for the treatment of allergy
11/02/2004	US6811781 Composition and method for diagnosing auto-immune hepatitis
11/02/2004	US6811780 Concurrent administering of cytokine antagonist and vaccine
11/02/2004	US6811779 Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
11/02/2004	US6811778 Method for improving oxygen transport by stored red blood cells
11/02/2004	US6811777 Compositions and minimally invasive methods for treating incomplete connective tissue repair
11/02/2004	US6811774 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
11/02/2004	US6811773 Human monocyte colony inhibitory factor (M-CIF) polypeptides
11/02/2004	US6811768 Use of inhaled NO as anti-inflammatory agent
11/02/2004	US6811767 Liquid droplet aerosols of nanoparticulate drugs
11/02/2004	CA2364251C Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
11/02/2004	CA2329486C Reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars
11/02/2004	CA2317736C Bisulfate salt of hiv protease inhibitor
11/02/2004	CA2277554C Streptokinase mutants
11/02/2004	CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
10/2004
10/28/2004	WO2004092731A1 Element having bioactive substance fixed thereto
10/28/2004	WO2004092404A2 Inhibitors of acidic mammalian chitinase as asthma therapeutics
10/28/2004	WO2004092395A2 Modulators of telomere stability
10/28/2004	WO2004092383A2 RNA INTERFERENCE MEDIATED INHIBITION OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) VIRUS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
10/28/2004	WO2004092379A2 Method for treatment of angiogenic disorders
10/28/2004	WO2004092378A2 Method for treatment of cancerous angiogenic disorders
10/28/2004	WO2004092361A1 Process for isolating and purifing ovine hyaluronidase
10/28/2004	WO2004092360A2 The severe acute respiratory syndrome coronavirus
10/28/2004	WO2004092343A2 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution
10/28/2004	WO2004092340A2 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
10/28/2004	WO2004092339A2 Modulation of muc1 mediated signal transduction
10/28/2004	WO2004092218A1 Process for producing recombinant antithrombin
10/28/2004	WO2004092216A1 Carcinoembryonic antigen (cea) lacking a signal peptide, nucleic acid encoding it and fusion of cea with a t cell epitope and their use for the treatment and/or prophylaxis of cancer
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004092213A1 Gene expressed in prostate cancer, methods and use thereof
10/28/2004	WO2004092210A2 Molecules having immunomodulatory activity
10/28/2004	WO2004092207A2 Respiratory syncytial virus (rsv) peptides
10/28/2004	WO2004092206A1 Novel peptide, immunopotentiator and functional food and process for producing functional food
10/28/2004	WO2004092205A1 Hydroxy-substituted-20-acyloxy-camptothecin polymer derivatives and use of the same for the manufacture of a medicament
10/28/2004	WO2004092204A1 Identification of n-alkylglycine trimers for induction of apoptosis
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004092195A2 Dendritic cell binding proteins and uses thereof
10/28/2004	WO2004092162A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/28/2004	WO2004092161A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/28/2004	WO2004091723A1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
10/28/2004	WO2004091679A1 Cellular preparation
10/28/2004	WO2004091667A1 Uptake of macromolecules
10/28/2004	WO2004091661A1 Remedy for diabetes
10/28/2004	WO2004091654A1 Vav inhibition in graft rejection
10/28/2004	WO2004091653A1 Interferon beta in severe acute respiratory syndrome (sars)
10/28/2004	WO2004091652A1 Pharmaceutical composition containing interferon for the treatment of hpv infections
10/28/2004	WO2004091651A1 Prongf as a pharmaceutically active agent for treating demyelinating diseases
10/28/2004	WO2004091650A1 Application of cardiac troponin i in preparing antitumour medicaments

1 ... 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 ... 3163